The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(1E,4E)-1-(1-(sec-Butyl)-1H-imidazol-2-yl)-5-(pyridin-2-yl)penta-1,4-dien-3-one ID: ALA4211207
PubChem CID: 145964784
Max Phase: Preclinical
Molecular Formula: C17H19N3O
Molecular Weight: 281.36
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCC(C)n1ccnc1/C=C/C(=O)/C=C/c1ccccn1
Standard InChI: InChI=1S/C17H19N3O/c1-3-14(2)20-13-12-19-17(20)10-9-16(21)8-7-15-6-4-5-11-18-15/h4-14H,3H2,1-2H3/b8-7+,10-9+
Standard InChI Key: SXZZPBMQCZOGNL-XBLVEGMJSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
17.1175 -12.6805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8319 -12.2680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8319 -11.4430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5464 -11.0305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5464 -10.2055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1175 -11.0305 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.2609 -9.7930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2609 -8.9680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9754 -8.5555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6898 -8.9680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6898 -9.7930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9754 -10.2055 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.1175 -13.5055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7849 -13.9904 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.5300 -14.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7050 -14.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4500 -13.9904 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.6654 -13.7354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4939 -12.9285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7093 -12.6735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0523 -14.2875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 2 0
3 6 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
7 12 2 0
5 7 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
13 17 1 0
18 19 1 0
19 20 1 0
18 21 1 0
17 18 1 0
1 13 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 281.36Molecular Weight (Monoisotopic): 281.1528AlogP: 3.54#Rotatable Bonds: 6Polar Surface Area: 47.78Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.02CX LogP: 3.47CX LogD: 3.45Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.76Np Likeness Score: -0.93
References 1. Zhang X, Guo S, Chen C, Perez GR, Zhang C, Patanapongpibul M, Subrahmanyam N, Wang R, Keith J, Chen G, Dong Y, Zhang Q, Zhong Q, Zheng S, Wang G, Chen QH.. (2017) Asymmetric 1,5-diarylpenta-1,4-dien-3-ones: Antiproliferative activity in prostate epithelial cell models and pharmacokinetic studies., 137 [PMID:28601720 ] [10.1016/j.ejmech.2017.05.062 ]